With Topical Zinc Sulphate (15%)
With Topical Zinc Sulphate (15%)
With Topical Zinc Sulphate (15%)
Abstract
from the breakdown product of amino acids. 2021.Fifty patients, 31 males and 19 females
Another microorganism that contributes to with tinea pedis were involved in this work.
the feet odor is the Staphylococcus Study design
epidermidis that produce isovaleric acid by The chief compliant is the tinea pedis
the degradation of the leucine that present in (interdigital type) in all patients that
the sweat and give a strong cheesy odor [7, attending to the Unit of Dermatology were
8]. only included regardless the age and sex.
Zinc is an important micronutient that is an Full history were including: age of patients,
essential component for more than 300 sex, marital status, residence, social status,
metalloenzymes that involved in a variety in job, and history of the disease itself,
metabolic pathways and cellular functions, including the duration, complaint of the
that include the antioxidant enzymes, patient, duration, associated with odor,
superoxide dismutase and affects their family history, any seasonal variations and
stability, conformity, and activity [9]. Zinc what is the aggravating factors. A socks
sulphate was effective in the treatment of type that been used, frequency of changes
many skin diseases, where it used in the per day and type of the shoes also asked to all
topical, intralesional or systemic formula , patients. In addition to history of drug intake
like acne vulgaris [10], recurrent oral that associated with sweating including
aphthus [11] , cutanous leishmaniasis aspirin, fluoxetin and insulin.
[12,13],many form of viral warts like plane The assessment of severity of the disease in
warts [14],other viral infections [15,16], all cases was performed including :clinical
Tinea versicolor [17],and dermatophytes examination to the lesion, and address the
fungal infections [18].The action of zinc site, any changing in color , presence any of
sulphate by the different mechanism of action the dry scales, wet scales ,maceration ,
that may be as antioxidant, erythema and skin scraping test .Also the
immunomodulator, antiviral, anti-fungal , associated feet odor was assessed and scored.
astringent, while it is cytotoxic in high Evaluation of the patients was done every
concentration [19]. two weeks for one month and follow up was
So, objective of the study is to compare the carried out. Photo for all lesions of the
efficacy of topical 15% zinc sulphate solution patients were taken by a digital camera
in the managment of Athlete's feet in versus (Sony:Cyber shoot with resolution 9 mega
the topical clotrimazole solution. pixels), as a first visit(baseline) and then
Patients and Methods every other 14 days, in the same
Study protocol circumstances (place with fixed illumination
The single-blind, comparative therapeutic and distance).
study using topical 15% zinc sulphate Study population
solution with 1% clotrimazole solution for Exclusion criteria: patients were received
the management of tinea pedis was executed no therapy for tinea pedis in the last two
in the Unit of Dermatology, BaqubaTeaching months prior the study. Patients with diabetes
Hospital between March 2020- July mellitus or atherosclerosis that may cause
complications in the feet; deformity and significant when less than 0.05, It done by
malformation of the feet and Excell 2010, SPSS version 20 statistical
immunosuppressant conditions were also program.
excluded from the study. Results
Preparations Group A: Twenty five patients 16 (64%)
Fifteen percent of the zinc sulphate males, 9 (36%) females involved in this
solution 15% (W/V) was produced by group, with ages ranged from 27-73 and a
thawing zinc sulphate crystals (ZnSO4 mean± SD of 47.8±12.18 years. While the
7H2O=287.54 It is manufactured by: Thomas disease duration ranged between 1-120 and a
Bekar India), 15 grams in 100 ml of Distilled mean± SD of 43±46.61 months. Also
Water, and kept in cleaned container at the repeated foot washing ranged from 2-10 with
room temperature of hospital and a mean± SD of 5.24±2.66 times/day. Twenty
Clotrimazole(1% )solution is obtained from four (96%) patients had a feet odor and the
MEDICO LABS _SYRIA. manner of feet odor was cheesy odor in 20
Clinical response score (80%) patients and vinegar odor in 4 (16%)
No clearance: - If there is no any response cases while 8 (32%) patients had itching. 17
while clinically examine and no change in (68%) of cases presented with seasonal
scoring of feet odor. variation with tinea pedis that worsened
Partial clearance: - If there is some clinical during the summer time, while 16(64%) of
improvement,like change of wet scales into patients had associated with plantar
dry scales, abscence in scales and change in hyperhydrosis.While 10 (40%) cases madet
feet odor. drying of foot after the washing as a habit
Complete clearance: - There is complete while others were not.
clearance of rash and odor The socks types were nylon in 17(68%),
Scoring of feet odor cotton 6(24%) and wool 1(4%) patient.
The scoring system had been used to assess Frequency of socks changes around the day
the patients with bared feet and any odor and of was presented in 15(60%) patients. The
to evaluate the odor intensity in that case and shoes types of were leather 9(36%), sandal
involve four points: 10(40%), and rubber 6(24%) patients.
Score 0: No any odor. Histories of drugs were aspirin in 5(20%)
Score1: mild; the odor is smell only when patients while 7 (28%) patients presented
the patient's finger put between the toe webs with positive family history of tinea pedis.
of his sole. The factors that aggravating of tinea pedis
Score2: Moderate; when the doctor in close were the hyperhidrosis present in 7(28%),
to the patient can smell the odor. occlusive the feet wear in 10(40%) and
Score 3: Severe; the surrounding people can nylon socks 8(32%) patients Table (1).
smell the odor. Scoring of feet odor before treatment was
Statistical Analysis Score 0: in 1(4%) patients, Score 1: 20(80%)
It done by Excell 2010, SPSS version 20 patients and Score 2: 4(16%) patients Table
statistical program.P_value is considered (2).
Group B: Twenty five patients presented The clinical assessment among tinea pedis
with tinea pedis were involved in this study, patients
10(40%) females and 15 (60%) males. The Group A: Clinical scoring of the odor in the
ages were ranged from 24-65 with a mean± tinea pedis after 2 weeks of treatment was
SD of 43.2±11.83 years, and the disease Score 0: 1 (4%) patient. Score 1: 20 (80%)
duration were ranged from 1-180 months, patients that changed into score 0 in 10(50%)
and the mean± SD of 30.24±44.9 months. patients, and not changed in 10(50%)
Also repeated foot washing ranged from 1-10 patients. Score 2: 4 (16%) patients changed
and the mean± SD of 4.84±2.15 times/day. into score 0 in 2(50%) patients, and not
Twenty (80%) of patients had feet odor and changed 2(50%).
also the tinea pedis, while 8 (32%) patients Scoring of the Athlete's feet odor after one
reported a positive family history of tinea month of treatment was:
pedis, itching was found in 9 (36%) patients. Score 0: 1 (4%) patient. Score 1: 20 (80%)
The quality of odor was cheesy odor in 20 patients changed into score 0 in 12(60%)
(80%) patients and vinegar odor in 2 (8%) patients, and not changed in 8(40%) patients.
patients.While 12 (48%) of caseshad history Score 2: 4 (16%) of patients that changed
of variation around the seasons with worse into score 0 in 2(50%) patients, and score 1
odor during the summer time, and 19(76%) in 1(25%) patient and no change 1(25%)
of patients had associated with plantar Table (2).
hyperhidrosis,and 12 (48%) patients had After two weeks of treatment, 2(8%)
drying habit to the feet after washing while patients showed complete clearance, 9(36%)
others were not. patients had partial of clearance and 14(56%)
Types of the socks that used by patients patients that showed no response Table (4).
were nylon in 10(40%) patients, cotton While clinical response after four weeks of
6(24%) and wool 4(16%) patients. Daily the treatment was 10(40%) patients was
changed frequency of the socks were complete clearance, 5(20%) patients had
presented in 10(40%) patients and others not. partial clearance and 10(40%) patients
Types of the shoes were: leather 10(40%), showed no response.
sandal 12(48%) and rubber 3(12%) patients. The clinical response in that patients have
History of drugs was: aspirin in 2(8%) the difference between two weeks and four
patients. weeks and was significant (chi square 7.14 P
Factors that may aggravate of the feet odor value =0.03).
were occlusive feet wear 10(40%) , Itching and burning sensation in 4(16%)
hyperhidrosis in 10(40%) patients, and nylon patients on treatment were mild side effects
socks 5(20%) patients Table (1). and these did not require discontinuation of
Scoring of the odor before starting the the drugs.
therapy was Score 0: in 3 (12%) cases, Group B: Scoring of the odorin tinea pedis
Score 1: in 20 (80%) cases and Score 2: in 2 foot after 2 weeks of treatment was
(8%) cases Table (3) Score0: 3 (12%) patients. Score1: 20 (80%)
patients that changed into the score 0 in 15
(75%) patient, and thre is no clinical complete response, 2 (8%) patients had
diffrence in 5 (25%) of cases. Score2: 2 (8%) partially responded, and 4 (16%) patients
patients changed into score 1 in 1(50%) showed no response Table (4).
patient and no difference in 1 (50%). The clinical response was also significant
Scoring of the odor of feet after one month of (chi square 20.12 P value =0.000043) in that
treatment was: patients between two weeks and four weeks
Score 1: 20 (80%) patients changed into of treatment.
score 0 in 17 (85%) of the cases, and no Side effects of treatment were mild which
changed in 3(15%) patients. Score2: 2 (8%) included itching and burning sensation in
changed into score1 in 2 (100%) patients 1(4%) patient. These side effects did not
Table (3). require discontinuation of the medicine.
After two weeks of beginning of the There was no significant difference
treatment, 4 (16%) patients showed complete statistically in two weeks (chi square 5.37 P
clearance, 15 (60%) patients had partially value =0.07) in the comparison between
clearance and 6 (24%) patients with no group A and B ,but was slightly significant at
response Table (4). four weeks (chi square 6.65, P value =0.04).
While clinical response after four weeks from
the treatment was 19 (76%) patients was
Table (1): Study groups description the (tinea pedis)
Group (A) Group (B)
Number (%) Number (%)
1- Family history 7 28 8 32
2-Iching 8 32 9 36
4-Type of odor
--Cheesy odor 20 80 20 80
- Vinegar odor 4 16 2 8
5- Associated with sweating 17 68 19 76
6-Season variation 16 60 12 48
7-Drying of feet 10 40 12 48
8-Types of socks
-Nylon 17 68 10 40
-Cotton 6 24 6 24
-Wool 1 4 4 16
-Daily changing 15 60 10 40
9-Types of shoes
- Leather 9 36 10 40
-Sandal 10 40 12 48
-Rubber 6 24 3 12
10-Drugs history
-Aspirin 5 20 2 8
11-Aggravating factors
-Hyperhydrosis 7 28 10 40
-Occlusive footwear 10 40 10 40
-Nylon socks 8 32 5 20
Scoring
Score 0 Score1 Score2(4) %
before Scoring % % % total
(1) pt (2) pt pt
therapy
Table (3): Feet odor scoring of the (Group B) after one month of treatment
Scoring
before Score 0 Score1(2 Score2 %
Scoring % % % total
treatmen (3) pt 0) pt (2) pt
t
Scoring Score0 3 100 17 85 0 0 20 80
after Score1 0 0 3 15 2 100 5 20
Therapy Score2 0 0 0 0 0 0 0 0
n. % n. % n. % n. % n. % n. %
Group A 14 56 9 36 2 8 10 40 5 20 10 40
Group B 6 24 15 60 4 16 4 16 2 8 19 76
Figure (1A): Tinea pedis(interdigital type) before 15% topical zinc sulfate solution application
Figure (1B): Same patient above after one month of 15% topical zinc sulfate solution application
infections, wearing closed shoes and socks University of Diyala ethical committee for
[7]. this study.
The study showed that zinc sulfate was Conflict of interest: Nil
good agent in clearance of feet odor and References
probably work through its antibacterial and [1] Leyden JL. Tinea pedis: Pathophysiology
antifungal actions. and treatment. J Am Acad Dermatol 1994; 31
Zinc is an essential trace element that has (3 Pt 2): S31-S33
direct anti-dermatophytes action in vivo and [2] Odom RB. Pathophysiology of
vitro [25] ,and had been shown to be an dermatophyte infections. J Am Acad
effective remedy in the treatment of pityriasis Dermatol 1993; 28 Suppl.: S2-S7
versicolor,Sharquie et al observed complete [3] Raboobee N, Aboobaker J, Peer AK.
clinical and mycological clearance after 3 Tinea pedis et unguium in the Muslim co
weeks treatment with 15% of zinc sulphate in mmunity of Durban, South Africa. Int J
the treatment of tinea versicolor [17],and Dermatol 1998; 37: 759-65
other superficial fungal infection [4]Shannon Verma,Michael P.
[18].Sharquie et al in a single blinded Heffernan.Superficial Fungal Infection, In:
placebo controlled therapeutic trial studied Fitzpatrick's Dermatology in General
the efficacy of 15% zinc sulphate solution for Medicine. Wolff, Klaus; Goldsmith, Lowell
the treatment of foot odor [27]. A.; Katz, Stephen I.; Gilchrest, Barbara A.;
Conclusions Paller, Amy S.;Leffell,David J. 7th ed. By
Topical solution of 15% zinc sulphate was McGraw-hill companies,Inc.2008;188:1808-
an effective treatment for tinea pedis and 1828.
clearance of feet odor. [5]Petranyi G, Ryder NS, Stütz A.
Recommendations Allylamine derivatives: New class of
Our knowledgement To be better, the synthetic antifungal agents inhibiting fungal
study that carried out and were observe the squalene epoxidase. Science 1984; 224:
Zinc sulphate is an effective mode of 1239-41
treatment that used in the management of [6] Birnbaum JE. Pharmacology of the
tinea pedis as 40% of patients had complete allylamines. J Am Acad Dermatol 1990; 23:
clearance but it was less superior than 782-5.
clotrimazole solution which gave76% [7] Kanda.F, Yagi.E, Fukuda.M, Knakajima,
clearance rate. Ohta.T and Nakata.O Elucidation of chemical
To increase the effectiveness of topical zinc compounds responsible for foot malodor Br J
sulphate a higher concentration like 25% is Dermatol .1990, 122, 771-776.
recommended [26]. [8] Arake,Hama M, Akibas, Koike K,
Source of funding: The current study was Okisaka K, Hagurat, Kamiya T, Tomita F.
funded by our charges with no any other Foot odor due to microbial metabolism and
funding sources elsewhere. its control. Can J Microbial. 2006 Apr:
Ethical clearance: Ethical approval was 52(4):357-64
obtained from the College of Medicine /
[9] Ananda S, Prasad. Zinc, the biology and solution. In: Iraqi Journal of Community
therapeutic of an ion. Annals of Internal Medicine 2008; 21(1): 61-62.
Medicine. 1996; 125(2): 142-143. [18] Al-Tereihi IG. Topical 10% zinc
[10] Sharquie KE, Noaimi AA, Al-Salih sulphate solution in the treatment of
MM. Topical therapy of acne vulgaris using superficial fungal infections. A thesis
2% tea lotion in comparison with 5% zinc submitted to the Iraqi Board for Medical
sulphate solution. Saudi Med J 2008; 29: Specializations, Dermatology and
1757-1761. Venereology, 2006.
[11] Sharquie KE, Najim RA, Al-Hayani RK, [19] Sharquie KE, Noaimi AA, Kadir NO.
Al-Nuaimy AA, Maroof DM. The Topical therapy of xeroderma pigmentosa
therapeutic and prophylactic role of oral zinc with 20% zinc sulphate solution. Iraqi
sulphate in management of recurrent Postgraduate Medical Journal 2008; 7(3):
aphthous stomatitis (RAS) in comparison 231-236.
with dapsone. Saudi Med J 2008; 29(5): 734- [20] Rothman S, Knox G, Windhorst D.
8. Tinea pedis: a source of infection in the
[12]Sharquie KE, Al-Azzawi K. Intralesional family.Arch Dermatol 1957; 75: 270–1.
therapy of cutaneous leishmaniasis with 2% [21] Jones HE, Reinhardt JH, Rinaldi MG. A
zinc sulphate solution. J Pan-Arab League clinical, mycological and immunological
Dermatologists. 1996; 7: 41-46. survey of dermatophytes. Arch Dermatol
[13] Sharquie KE, Najim RA, Al-Timimi DJ, 1973; 108: 61–8.705–7.
Farjou IB. Oral zinc sulphate in the treatment [22] Mawlud AO & Sharquie KE. A Survey
of acute cutaneous leishmaniasis. Clin Exp of Superficial Fungal Infections of Skin. In
Dermatol 2001; 26: 21-26. the journal of the Iraqi Medical Association
[14] Sharquie KE, Khorsheed AA, Al- 1993;42:177-183.
Nuaimy AA. Topical zinc sulphate solution [23]Rinaldi MG. Dermatophytosis:
for treatment of viral warts. Saudi Med J epidemiological and microbiological update.
2007; 28(9): 1418-21. J Am Acad Dermatol. 2000;43:S120–S124
[15]Sharquie KE, Al-Nauaimy AA. [24] Kardjeva V, Summerbell R, Kantardjiev
Treatment of viral warts by intralesional T et al. Fourty eight hour diagnosis of
injection of zinc sulphate. Annals Saudi Med onychomycosis with subtyping of strains of
2002; 22(1-2): 26-28. Trichophyton rubrum strains. J Clin
[16] Al-Gurairi F, Al-Waiz M, Sharquie KE. Microbiol 2006; 44: 1419–27.
Oral zinc sulphate in the treatment of [25] Al-Janabi SJ. Dermatophytes infections
recalcitrant viral warts: Randomized placebo in Baghdad: Clinical and laboratory study.
controlled trial. Br J Dermatol 2002; 146: PhD Thesis in Microbiology and Mycology,
423-31. College of Education – University of
[17] Sharquie KE, Al-Dori WS, Sharquie IK Baghdad, 2006.
and Noaimi AA. Treatment of pityriasis [26] Sharquie KE, Al-Mashhadani SA,
versicolor with topical 15% zinc sulphate Noaimi AA ,Hassan AA. Topical zinc
sulphate (25%) solution: A new therapy for
actinic keratosis. J cutenous and anesthetic effective therapy for feet odor. Journal of
surgery 2012;1(5). Cosmetic , Dermatological Sciences and
[27] Sharquie EE,Noaimi AA, Hameed SD. Applications. 2013;3:203_208.
Topical 15% zinc sulphate solution is an
دراسة منفردة التعمية مقارنة لعالج سعفة القدم بسلفات الزنك %15مقارنة بمحلول
الكلوتريمازول %1
3
سعد ظاهر حميد , 1سرمد يحيى عبود , 2عطاء اكرم قدوري
الملخص
خلفية الدراسة :سعفة القدم هو عدوى فطرية جلدية تبدء بين اصابع القدمين عادة وهي شائعة لدى االشخاص الدين تصبح
اقدامهم شديدة التعرق اثناء انحشارها داخل االحدية الضيقة.
اهداف الدراسة :لتقييم فعالية سلفات الزنك %15في عالج سعفة القدم بالمقارنة مع محلول الكلوتريمازول . %1
المرضى والطرائق :تجربة منفردة التعمية ومقارنة امالح سلفات الزنك %15مقارنة ب الكلوتريمازول ,%1في مستشفى
بعقوبة التعليمي ,قسم المرضى ال مجموعتين ,مجموعة (ا) عولجت بسلفات الزنك %15مرتين يوميا ,مجموعة (ب) عولجت
بمحلول الكلوتريمازول %1مرتين يوميا .مع المتابعة كل اسبوعين.
النتائج :مجموعة (ا) 25مريض مدة المرض 120-1شهر عولجت بسلفات الزنك وبعد المتابعة باربعة اسابيع من العالج كان
الشفاء التام %40و %40لم يستجيبوا للعالج ,ومجموعة (ب) 25مريض عالجها بمحلول الكلوتريمازول وكانت مدة
المرض بين 180-1شهر ,وبعد اربعة اسابيع من العالج كان الشفاء التام %76و %16لم يستجيبوا للعالج.
االستنتاجات :امالح سلفات الزنك %15فعالة في عالج سعفة القدم ,لكن الكلوترمازول فعال اكثر.
الكلمات المفتاحية :سعفة القدم ،كبريتات الزنك الموضعية ،كلوتريمازول
البريد االلكترونيSum_sum112233@yahoo.com :
تاريخ استالم البحث 2 :نيسان 2023
تاريخ قبول البحث 6 :آب 2023